Skip to content
Search

Latest Stories

Government announces £15 billion funding for New Hospital Programme

All projects in the New Hospital Programme will be delivered – government confirms; £15B hospital funding
4th January 2023. Luton, Bedfordshire. NHS Emergency Ambulance at Luton and Dunstable NHS Hospital. (gettyimages)

The previous government pledged to build 40 new hospitals by 2030 but 'not a single new hospital was built in the past five years'

The Labour government has confirmed that all projects in the New Hospital Programme will be delivered, backed by a £15 billion investment spread over consecutive five-year waves.

The announcement follows a review of the scheme which found that the previous government’s commitment to build 40 new hospitals by 2030 was “behind schedule, unfunded and therefore undeliverable.”


The Infrastructure Projects Authority (IPA) highlighted these issues in its annual report published last week, rating the previous scheme as 'red'.

Following an independent review by IPA, the New Hospitals Programme's rating was upgraded to 'amber,' reflecting steps taken to improve deliverability.

In May 2023, the former government had claimed the programme was supported by over £20 billion, but this funding was never delivered.

Health secretary Wes Streeting said: “The New Hospital Programme we inherited was unfunded and undeliverable.”

“Not a single new hospital was built in the past five years, and there was no credible funding plan to build forty in the next five years.”

He assured that the current government has set out “an honest, funded, and deliverable” plan to rebuild the NHS.

Morag Stuart, chief programme officer for the New Hospital Programme, emphasised ongoing collaboration with local NHS organisations to enhance hospitals across England.

These include making the best use of new technology, improving layouts and designing future hospitals to meet the needs of patients and staff.

The New Hospital Programme is part of the government’s wider commitment to transform the NHS estate.

Over £1 billion has been allocated to address the backlog of critical maintenance, repairs and upgrades, with an additional £102 million earmarked for upgrading GP surgeries across England.

Building an NHS estate that is fit for the future is key to the government’s Plan for Change, which aims to restore the health service and reduce waiting times.

At the Budget, the Chancellor announced that NHS health capital spending would increase to record levels of £13.6 billion in 2025-26.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less